Hangzhou Leap Chem Co., Ltd. is one of the most professional manufacturers and suppliers of cyclopentolate hydrochloride丨cas 5870-29-1 in China. Welcome to wholesale custom made chemical products at competitive price from our factory. For more cheap products, contact us now.
↵
Specifications
| Description | White to slightly yellow crystalline powder |
| Solubility | Very soluble in water, freely soluble in alcohol, insoluble in ether |
| Identify | HPLC and IR |
| Melting Point | 135°C to 138°C |
| pH | 4.5 to 5.5 |
| Loss on Drying | 0.5% max |
| Residue on Ignition | 0.1% max |
| Related Substance | 0.5% max |
| Chromatographic Purity (by HPLC) | 2% max |
| Toluene | 500 ppm max |
| Ether | 4000 ppm max |
| Ethyl Acetate | 4000 ppm max |
| Assay (by HPLC) | 98% to 102% (dried substance) |
Applications
Cyclopentolate hydrochloride is a widely used ophthalmic agent, primarily applied in eye care and clinical ophthalmology. It functions as a muscarinic antagonist, blocking the responses of the sphincter muscle of the iris and the ciliary body to cholinergic stimulation. This action induces mydriasis (pupil dilation) and cycloplegia (paralysis of accommodation), which are essential for diagnostic eye examinations such as fundoscopy and refraction assessments, particularly in pediatric patients. Beyond diagnostic use, it is employed preoperatively in ophthalmic surgeries to facilitate procedures requiring a dilated pupil. In certain therapeutic contexts, cyclopentolate hydrochloride is also used to manage uveitis by reducing pain and preventing the formation of posterior synechiae. Its reliable pharmacological action makes it an indispensable tool in modern ophthalmology.
Benefits
The key benefits of cyclopentolate hydrochloride lie in its effectiveness, rapid onset of action, and safety profile when administered under medical supervision. It provides reliable and reversible pupil dilation, enabling accurate eye examinations and reducing the risk of misdiagnosis due to inadequate visualization of the retina or optic nerve. Compared to some alternatives, it achieves cycloplegia efficiently, making it particularly valuable for pediatric refraction studies where precise results are necessary for prescribing corrective lenses. Additionally, its therapeutic role in alleviating ocular discomfort in inflammatory conditions supports patient comfort and helps prevent long-term complications. The compound's predictable pharmacodynamics, relatively short duration of action compared to longer-lasting agents, and broad acceptance in ophthalmic practice contribute to its continued preference in clinical use.
Conclusion
In summary, cyclopentolate hydrochloride is an important ophthalmic drug with widespread applications in diagnostic, surgical, and therapeutic eye care. Its ability to provide rapid and effective mydriasis and cycloplegia supports accurate examinations, successful surgical interventions, and improved patient outcomes in inflammatory conditions. The compound's benefits, including safety, efficacy, and patient comfort, ensure its ongoing role as a critical agent in ophthalmology. With its established clinical value, cyclopentolate hydrochloride remains a cornerstone in advancing precise and effective eye care practices.
